Showing results (121-130 of 301) with videos related to
Sort By:
Pageof 31
The Journal of Clinical Investigation|April 1, 2022
The FoxOs are in the ApoM houseMacRae F Linton, Patricia G Yancey, Zoe M Leuthner, et al.Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2016
Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid ArthritisMichelle J Ormseth, Patricia G Yancey, Joseph F Solus, et al.American Journal of Physiology. Renal Physiology|March 4, 2011
Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesityLi-Jun Ma, Bridgette A Corsa, Jun Zhou, et al.Nature|June 8, 2007
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2Masato Furuhashi, Gürol Tuncman, Cem Z Görgün, et al.American Journal of Physiology. Heart and Circulatory Physiology|September 10, 2021
Impaired macrophage trafficking and increased helper T-cell recruitment with loss of cadherin-11 in atherosclerotic immune responseCamryn L Johnson, Lance Riley, Matthew Bersi, et al.IJC Metabolic & Endocrine|March 1, 2017
Net cholesterol efflux capacity of HDL enriched serum and coronary atherosclerosis in rheumatoid arthritisMichelle J Ormseth, Patricia G Yancey, Suguru Yamamoto, et al.F1000Research|March 17, 2017
Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular diseaseMichael D Shapiro, Sergio FazioJournal of Atherosclerosis and Thrombosis|March 18, 2017
PCSK9 and Atherosclerosis - Lipids and BeyondMichael D Shapiro, Sergio FazioTransactions of the American Clinical and Climatological Association|July 18, 2020
PREVENTIVE CARDIOLOGY AS NEW SUBSPECIALTY OF CARDIOVASCULAR MEDICINESergio Fazio, Michael D ShapiroCirculation Research|February 20, 2016
From Lipids to Inflammation: New Approaches to Reducing Atherosclerotic RiskMichael D Shapiro, Sergio FazioPageof 31